Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study)

NARecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

May 31, 2026

Conditions
End Stage Renal Disease on Dialysis
Interventions
DEVICE

pHA130 Hemoadsorption + High-Flux Hemodialysis

A combination blood-purification procedure in which a pHA130 hemoperfusion cartridge is connected in series with a high-flux hemodialyzer. Blood first passes through the HP cartridge to adsorb protein-bound uremic toxins and is then dialyzed. In the 4-hour arm the HP cartridge remains online for the entire 4-hour session; in the 2-hour arm the cartridge is removed after 2 hours and dialysis continues alone for the remaining 2 hours. Blood-flow rates are 250-350 mL/min (4-hour arm) or 200-250 mL/min (2-hour arm).

Trial Locations (1)

Unknown

RECRUITING

Peking University People's Hospital, Beijing

All Listed Sponsors
lead

Peking University People's Hospital

OTHER

NCT07111260 - Efficacy of pHA130 Hemoadsorption for 4 Hours (p4H Study) | Biotech Hunter | Biotech Hunter